As of 2026, 5-Amino-1MQ is not approved by any health authority, including the MHRA
Subcutaneous AOD-9604 Community research plans often cite 300-500 mcg per day from a reconstituted vial
Modern Aminos works with manufacturing partners that emphasize process control, product consistency, and quality-focused production standards
Injecting into fat instead of muscle reduces absorption, so the dose may not work as intended
Preclinical studies in rodents have demonstrated reductions in fat mass, improved insulin sensitivity, and increased metabolic rate without significant changes to food intake (Neelakantan et al., 2019)
For consistency across studies, document solvent, concentration, storage temperature, freezethaw cycles, and light exposure conditions in experimental records